作者: Susan Joy Clark , Peter Laurence Molloy , Douglas S. Millar
DOI:
关键词:
摘要: A diagnostic or prognostic assay is disclosed for a disease of condition characterized by abnormal methylation cytosine at side sites within the glutathione-S-transferase (GST) Pi gene and/or its regulatory flanking sequences (e.g., prostate cancer and liver cancer). The comprises: (i) isolating DNA from said subject, (ii) determining selective PCR amplification) presence site GST-Pi sequences.